A detailed history of La Financiere De L'Echiquier transactions in Eli Lilly & CO stock. As of the latest transaction made, La Financiere De L'Echiquier holds 33,830 shares of LLY stock, worth $30.6 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares
33,830
Previous 30,260 11.8%
Holding current value
$30.6 Million
Previous $17.6 Million 49.2%
% of portfolio
1.17%
Previous 0.85%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$592.2 - $792.28 $2.11 Million - $2.83 Million
3,570 Added 11.8%
33,830 $26.3 Million
Q4 2023

Jan 25, 2024

BUY
$525.19 - $619.13 $15 Million - $17.6 Million
28,500 Added 1619.32%
30,260 $17.6 Million
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $156,492 - $215,747
-360 Reduced 16.98%
1,760 $945,000
Q2 2023

Aug 10, 2023

BUY
$350.74 - $468.98 $743,568 - $994,237
2,120 New
2,120 $994,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track La Financiere De L'Echiquier Portfolio

Follow La Financiere De L'Echiquier and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of La Financiere De L'Echiquier, based on Form 13F filings with the SEC.

News

Stay updated on La Financiere De L'Echiquier with notifications on news.